Concordance of Hypoglycemia Measurement With Simultaneous Use of Two Devices for Continuous Glucose Measurement.

Save

Report Abuse

Description

The aim of this study is to compare two frequently used sensors for continuous glucose monitoring (CGM); Freestyle Libre and Dexcom G 7. More precisely, we want to investigate if there is any difference in the hypoglycemic area for these two devices.

Study Overview

Start Date
January 19, 2024
Completion Date
August 1, 2024
Enrollment
14
Date Posted
February 7, 2024
Accepts Healthy Volunteers?
No
Gender
All

Locations

Full Address
Silkeborg Regional Hospital
Silkeborg 8600, Denmark

Eligibility

Eligibility Criteria
Inclusion Criteria:

Type 1 diabetes Using Dexcom G 7 -

Exclusion Criteria:

Do not want to participate

-

Study Contact Info

Study Contact Name
Mia Christensen, MD; Klavs W Hansen, MD
Study Contact Email
Study Contact Phone

Contact Listings Owner Form

Concordance of Hypoglycemia Measurement With Simultaneous Use of Two Devices for Continuous Glucose Measurement. 0 reviews

Write Your Review

There are no reviews yet.

Write Your Review

Your email address will not be published. Required fields are marked *

Other Details

FDA Regulated Drug?
No
FDA Regulated Device?
No
Detailed Description
We are including adults with type 1 diabetes who already are using a Dexcom G 7, in their diabetes treatment. Simultaneously with their Dexcom G7, the participants will get the Libre 2 sensor attached, and are to wear this for a period of 14 days. The Libre sensor is a Freetsyle Libre 2. Glucose data are compared for paired values within a time interval of 5 min or less. In this way we have access to nearly simultaneous glucose values from two different CGM's. In addition, the participants are given a Contour Next One, and are asked to measure their blood glukose with fingerprick if their Dexcom registers a glucose value < 5 mmol/l.

By this project, we hope to gain more precise information about the two most widely distributed CGMs, and their function in the hypoglycemic area. This, can have impact on healthcare professionals' future therapeutic instructions, regarding the use of insulin adjustment and carbohydrate compensation.
NCTid (if applicable)
NCT06246578